Cargando…

Maternal Body Mass Index and Anovaginal Distance in Active Phase of Term Labor

INTRODUCTION: To evaluate if there was a difference in the anovaginal distance (AVD) measured by transperineal ultrasound between obese and normal weight women. MATERIAL AND METHODS: A prospective observational study including 207 primiparous women at term in first stage of labor. Transperineal ultr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjertberg, Linda, Uustal, Eva, Pihl, Sofia, Blomberg, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863348/
https://www.ncbi.nlm.nih.gov/pubmed/29707565
http://dx.doi.org/10.1155/2018/1532949
Descripción
Sumario:INTRODUCTION: To evaluate if there was a difference in the anovaginal distance (AVD) measured by transperineal ultrasound between obese and normal weight women. MATERIAL AND METHODS: A prospective observational study including 207 primiparous women at term in first stage of labor. Transperineal ultrasound with a vaginal probe was used to measure the AVD. Maternal, pregnancy, and delivery characteristics potentially associated with perineal thickness were extracted from woman's medical records. The participants were divided into three BMI groups based on maternal weight in early pregnancy: normal weight (BMI < 25), overweight (BMI 25–29.9), and obesity (BMI ≥ 30). Obese and overweight women were compared with normal weight women regarding the AVD. RESULTS: The mean AVD was 24.3, 24.9, and 27.0 mm in the normal weight, overweight, and obesity group, respectively. There were no group differences in background characteristics. The AVD was significantly longer in obese women compared with normal weight women (p = 0.018). CONCLUSIONS: The observed longer AVD in obese women might be protective of the anal sphincter complex, explaining lower rates of anal sphincter injuries in this group. Further studies are indicated to evaluate whether the length of the AVD plays a role in the risk assessment of obstetric anal sphincter injury. The trial is registered in ClinicalTrials.gov and the trial registration ID is NCT03149965.